The microbiome—a vast ecosystem of microbes within our bodies—is emerging as a foundational platform for health, influencing everything from immunity and digestion to mental health and drug response. Despite growing scientific evidence, the healthcare industry often treats it as a niche trend, limiting its potential. The article argues for a paradigm shift: to stop viewing the microbiome as a wellness product and start integrating it into diagnostics, chronic care, and personalized medicine. The future of healthcare, it suggests, may depend not on external innovation, but on unlocking the power of the microscopic world within us.
Trending
- USDH’s AI-Driven Colonoscopy Innovation and Market Expansion: A Disruptive Force in U.S. Preventive Medicine (AInvest)
- Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition (MedCity News)
- How to protect physician autonomy as GI consolidates (Becker’s GI & Endoscopy)
- GutGPT: A multidimensional knowledge-enhanced large language model for gastrointestinal medicine (ScienceDirect)
- 288 new CPT codes cover digital health, AI and more (AMA)
- The Prognostic Power of ctDNA Testing in Patients With Colorectal Cancer (Medscape)
- AI Is Becoming Private Equity’s New Playbook (Forbes)
- Rising colorectal cancer rates and ASCs: 5 things to know (Bevker’s GI & Endoscopy)